RNA in spinal muscular atrophy: therapeutic implications of targeting.

Expert Opinion on Therapeutic Targets
Ravindra N SinghNatalia N Singh

Abstract

Spinal muscular atrophy (SMA) is caused by low levels of the Survival Motor Neuron (SMN) protein due to deletions of or mutations in the SMN1 gene. Humans carry another nearly identical gene, SMN2, which mostly produces a truncated and less stable protein SMNΔ7 due to predominant skipping of exon 7. Elevation of SMN upon correction of SMN2 exon 7 splicing and gene therapy have been proven to be the effective treatment strategies for SMA. This review summarizes existing and potential SMA therapies that are based on RNA targeting.We also discuss the mechanistic basis of RNA-targeting molecules. The discovery of intronic splicing silencer N1 (ISS-N1) was the first major step towards developing the currently approved antisense-oligonucleotide (ASO)-directed therapy (SpinrazaTM) based on the correction of exon 7 splicing of the endogenous SMN2pre-mRNA. Recently, gene therapy (Zolgensma) has become the second approved treatment for SMA. Small compounds (currently in clinical trials) capable of restoring SMN2 exon 7 inclusion further expand the class of the RNA targeting molecules for SMA therapy. Endogenous RNA targets, such as long non-coding RNAs, circular RNAs, microRNAs and ribonucleoproteins, could be potentially exploited for d...Continue Reading

References

Sep 2, 1997·Proceedings of the National Academy of Sciences of the United States of America·B SchrankM Sendtner
May 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·C L LorsonB Wirth
Dec 30, 1999·Nature Genetics·H M Hsieh-LiH Li
Jul 2, 2003·Nature Genetics·Tsuyoshi Kashima, James L Manley
Feb 10, 2004·Biochemical and Biophysical Research Communications·Natalia N SinghRavindra N Singh
Jan 25, 2005·Critical Reviews in Eukaryotic Gene Expression·Natalia N SinghRavindra N Singh
Feb 20, 2007·Proceedings of the National Academy of Sciences of the United States of America·Tsuyoshi KashimaJames L Manley
Jun 27, 2007·RNA Biology·Ravindra N Singh
Mar 29, 2008·American Journal of Human Genetics·Yimin HuaAdrian R Krainer
Jun 19, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jason H WilliamsGordon J Lutz
Oct 19, 2010·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Ruben J Cauchi
Mar 4, 2011·Science Translational Medicine·Marco A PassiniSeng H Cheng
Oct 28, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Erkan Y OsmanChristian L Lorson
Dec 22, 2011·Human Molecular Genetics·Paul N PorenskyArthur H M Burghes
Dec 20, 2012·RNA·William R JeckNorman E Sharpless
Nov 23, 2013·Translational Neuroscience·Senthilkumar SivanesanRavindra N Singh
Feb 11, 2014·Annals of Clinical and Translational Neurology·W David ArnoldArthur H M Burghes
Apr 23, 2014·The Kaohsiung Journal of Medical Sciences·Li-Ting WangShih-Hsien Hsu
Jul 9, 2014·Molecular Therapy. Nucleic Acids·Jeffrey M KeilChristine J DiDonato
Jul 25, 2014·Human Molecular Genetics·Min Jeong KyeMustafa Sahin
Jul 30, 2014·Future Medicinal Chemistry·Matthew D HowellRavindra N Singh
Dec 4, 2014·Journal of Neuropathology and Experimental Neurology·Brian N HardingRichard S Finkel
Dec 17, 2014·PloS One·Claribel D WeeMichelle L Hastings
Mar 3, 2015·Annals of the New York Academy of Sciences·Natalia N SinghRavindra N Singh
Jun 2, 2015·Nature Chemical Biology·James PalacinoRajeev Sivasankaran
Jun 13, 2015·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Sarah Tisdale, Livio Pellizzoni
Sep 19, 2015·Future Medicinal Chemistry·Natalia N SinghRavindra N Singh

❮ Previous
Next ❯

Citations

Dec 8, 2020·Neuroscience Insights·Ravindra N SinghNatalia N Singh
Dec 16, 2020·Cells·Namjeong ChoiHaihong Shen
Nov 7, 2020·Epigenomics·Fabio Coppedè
Aug 28, 2021·International Journal of Molecular Sciences·Eric William OttesenRavindra Narayan Singh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Cajal Bodies & Gems

Cajal bodies or coiled bodies are dense foci of coilin protein. Gemini of Cajal bodies, or gems, are microscopically similar to Cajal bodies. It is believed that Cajal bodies play important roles in RNA processing while gems assist the Cajal bodies. Find the latest research on Cajal bodies and gems here.

© 2022 Meta ULC. All rights reserved